I
Immunome, Inc.
IMNM · NASDAQ · Healthcare · 2.6B
Closing price
$19.55
+1.24% · last session
Graham & Buffett's criteria
published figures · last financial year
Price / earningsP/E
—
Price / net assetsP/B
2.7×
Enterprise value / EBITDAEV/EBITDA
-5.1×
Free cash flow yieldFCF yield
-11.7%
Return on equityROE
-33.5%
Operating margin
-3084.8%
Net debt / EBITDAbalance-sheet strength
3.1×
Interest coverage
—
How we read it
an educational summary · not advice
Figures provided for information and education — they do not constitute personalized investment advice. Investing carries a risk of capital loss.